{"id":33304,"date":"2026-03-23T14:15:44","date_gmt":"2026-03-23T19:15:44","guid":{"rendered":"https:\/\/myeloma.ca\/?page_id=33304"},"modified":"2026-07-30T16:15:21","modified_gmt":"2026-07-30T21:15:21","slug":"formation-clinique","status":"publish","type":"page","link":"https:\/\/myeloma.ca\/fr\/science-et-recherche\/formation-clinique\/","title":{"rendered":"Formation clinique et lignes directrices"},"content":{"rendered":"<div class=\"page-intro-block   block_8e6d910dbea3c7a114fc19d5c38141f4\">\n    <div class=\"container\">\n        <div class=\"left-content\">\n            <div class=\"content\">\n                <h1><strong class='second-font-family is-italic is-italic-fw'>Formation clinique<\/strong> et lignes directrices<\/h1>\n            <\/div>\n            <div class=\"bottom-content\">\n                <div class=\"actions-btns-wrapper\">\n                    <a class=\"print-btn\" href=\"#\">\n                        <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"13.545\" height=\"14.195\" viewBox=\"0 0 13.545 14.195\"><path d=\"M13.786,9.785v-2.6H7.759v2.6H6.743V6H14.8V9.785Zm-8.77,1.183h0Zm10.142,1.873a.457.457,0,0,0,.356-.177.639.639,0,0,0,0-.828.445.445,0,0,0-.711,0,.639.639,0,0,0,0,.828A.457.457,0,0,0,15.158,12.841Zm-1.371,6.171V15.227H7.759v3.785ZM14.8,20.2H6.743v-3.47H4v-4.85a2.2,2.2,0,0,1,.516-1.489,1.619,1.619,0,0,1,1.278-.6H15.75a1.619,1.619,0,0,1,1.278.6,2.2,2.2,0,0,1,.516,1.489v4.85H14.8Zm1.727-4.653V11.875a.963.963,0,0,0-.22-.651.7.7,0,0,0-.559-.256H5.795a.7.7,0,0,0-.559.256.963.963,0,0,0-.22.651v3.667H6.743v-1.5H14.8v1.5Z\" transform=\"translate(-4 -6)\" fill=\"#3e3a3b\"\/><\/svg>\n                        <span>Imprimer<\/span>\n                    <\/a>\n                    <a class=\"share-btn\" href=\"mailto:?subject=I wanted you to see this!&amp;body=https:\/\/myeloma.ca\/fr\/science-et-recherche\/formation-clinique\/\">\n                        <svg height=\"14.195\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 512 512\"><path d=\"M64 96c-17.7 0-32 14.3-32 32v39.9L227.6 311.3c16.9 12.4 39.9 12.4 56.8 0L480 167.9V128c0-17.7-14.3-32-32-32H64zM32 207.6V384c0 17.7 14.3 32 32 32H448c17.7 0 32-14.3 32-32V207.6L303.3 337.1c-28.2 20.6-66.5 20.6-94.6 0L32 207.6zM0 128C0 92.7 28.7 64 64 64H448c35.3 0 64 28.7 64 64V384c0 35.3-28.7 64-64 64H64c-35.3 0-64-28.7-64-64V128z\"\/><\/svg>\n                        <span>Partager<\/span>\n                    <\/a>\n                <\/div>\n                <div class=\"lb-breadcrumb\">\n                    <div class=\"lb-breadcrumbs\"><span><a href=\"https:\/\/myeloma.ca\/fr\/\">Accueil<\/a><\/span><span class=\"lb-breadcrumb-separator\"> | <\/span><\/div>                <\/div>\n            <\/div>\n\n        <\/div>\n    <\/div>\n    <div class=\"page-intro-image-wrapper\">\n\t\t<img loading=\"lazy\" decoding=\"async\" width=\"2560\" height=\"1707\" src=\"https:\/\/myeloma.ca\/wp-content\/uploads\/navymedicine-clinical-education-scaled.jpg\" class=\"attachment-full size-full\" alt=\"\" srcset=\"https:\/\/myeloma.ca\/wp-content\/uploads\/navymedicine-clinical-education-scaled.jpg 2560w, https:\/\/myeloma.ca\/wp-content\/uploads\/navymedicine-clinical-education-300x200.jpg 300w, https:\/\/myeloma.ca\/wp-content\/uploads\/navymedicine-clinical-education-1024x683.jpg 1024w, https:\/\/myeloma.ca\/wp-content\/uploads\/navymedicine-clinical-education-768x512.jpg 768w, https:\/\/myeloma.ca\/wp-content\/uploads\/navymedicine-clinical-education-1536x1024.jpg 1536w, https:\/\/myeloma.ca\/wp-content\/uploads\/navymedicine-clinical-education-2048x1365.jpg 2048w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/>    <\/div>\n        <div class=\"left-content mobile\">\n            <div class=\"bottom-content\">\n                <div class=\"actions-btns-wrapper\">\n                    <a class=\"print-btn\" href=\"#\">\n                        <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"13.545\" height=\"14.195\" viewBox=\"0 0 13.545 14.195\"><path d=\"M13.786,9.785v-2.6H7.759v2.6H6.743V6H14.8V9.785Zm-8.77,1.183h0Zm10.142,1.873a.457.457,0,0,0,.356-.177.639.639,0,0,0,0-.828.445.445,0,0,0-.711,0,.639.639,0,0,0,0,.828A.457.457,0,0,0,15.158,12.841Zm-1.371,6.171V15.227H7.759v3.785ZM14.8,20.2H6.743v-3.47H4v-4.85a2.2,2.2,0,0,1,.516-1.489,1.619,1.619,0,0,1,1.278-.6H15.75a1.619,1.619,0,0,1,1.278.6,2.2,2.2,0,0,1,.516,1.489v4.85H14.8Zm1.727-4.653V11.875a.963.963,0,0,0-.22-.651.7.7,0,0,0-.559-.256H5.795a.7.7,0,0,0-.559.256.963.963,0,0,0-.22.651v3.667H6.743v-1.5H14.8v1.5Z\" transform=\"translate(-4 -6)\" fill=\"#3e3a3b\"\/><\/svg>\n                        <span>Imprimer<\/span>\n                    <\/a>\n                    <a class=\"share-btn\" href=\"mailto:?subject=I wanted you to see this!&amp;body=https:\/\/myeloma.ca\/fr\/science-et-recherche\/formation-clinique\/\">\n                        <svg height=\"14.195\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 512 512\"><path d=\"M64 96c-17.7 0-32 14.3-32 32v39.9L227.6 311.3c16.9 12.4 39.9 12.4 56.8 0L480 167.9V128c0-17.7-14.3-32-32-32H64zM32 207.6V384c0 17.7 14.3 32 32 32H448c17.7 0 32-14.3 32-32V207.6L303.3 337.1c-28.2 20.6-66.5 20.6-94.6 0L32 207.6zM0 128C0 92.7 28.7 64 64 64H448c35.3 0 64 28.7 64 64V384c0 35.3-28.7 64-64 64H64c-35.3 0-64-28.7-64-64V128z\"\/><\/svg>\n                        <span>Partager<\/span>\n                    <\/a>\n                <\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n\n\n<!-- EDIT ONLY THIS SECTION -->\n\n<script>\nconst sections = [\n  {\n    id: 'lignes-directrices',\n    label: 'Lignes directrices consensuelles'\n  },\n  {\n    id: 'fmc',\n    label: 'Formation m\u00e9dicale continue'\n  },\n  {\n    id: 'gmpq',\n    label: 'Groupe des maladies plasmocytaires du Qu\u00e9bec'\n  }\n];\n<\/script>\n\n\n<!-- DOT NAVIGATION -->\n<nav id=\"dot-nav\" aria-label=\"Page sections\" style=\"\n    position: fixed;\n    top: 50%;\n    transform: translateY(-50%);\n    z-index: 100;\n    display: flex;\n    flex-direction: column;\n    gap: 14px;\n    align-items: flex-start;\n  \"><\/nav>\n\n<!-- STYLES -->\n<style>\n#dot-nav {\n  left: 24px;\n}\n\n@media (max-width: 768px) {\n  #dot-nav {\n    left: 12px;\n  }\n}\n\n#dot-nav .dot-link {\n  display: flex;\n  align-items: center;\n  gap: 8px;\n  text-decoration: none;\n}\n#dot-nav .dot {\n  width: 7px;\n  height: 7px;\n  border-radius: 50%;\n  background: #ccc;\n  transition: background-color 0.2s;\n  flex-shrink: 0;\n}\n#dot-nav .dot.active {\n  background: #a6192e !important;\n}\n#dot-nav .dot-label {\n  font-size: 12px;\n  color: #3e3a3b;\n  opacity: 0;\n  transition: opacity 0.2s;\n}\n#dot-nav .dot-link:hover .dot-label {\n  opacity: 1;\n}\n<\/style>\n\n<!-- SCRIPT -->\n<script>\n(function () {\n  const nav = document.getElementById('dot-nav');\n  sections.forEach(section => {\n    nav.insertAdjacentHTML(\n      'beforeend',\n      `\n      <a href=\"#${section.id}\" class=\"dot-link\">\n        <span class=\"dot\"><\/span>\n        <span class=\"dot-label\">${section.label}<\/span>\n      <\/a>\n      `\n    );\n  });\n\n  let lastIdx = -1;\n\n  function tick() {\n    let activeIdx = -1;\n\n    \/* activate when anchor reaches middle of screen *\/\n    const triggerLine = window.innerHeight * 0.5;\n\n    sections.forEach((section, i) => {\n      const target = document.getElementById(section.id);\n      if (!target) return;\n      const top = target.getBoundingClientRect().top;\n      if (top <= triggerLine) {\n        activeIdx = i;\n      }\n    });\n\n    \/* turn off last dot after final section is gone *\/\n    const lastSection =\n      document.getElementById(\n        sections[sections.length - 1].id\n      );\n    if (lastSection) {\n      const rect =\n        lastSection.getBoundingClientRect();\n      if (rect.top < -window.innerHeight * 0.5) {\n        activeIdx = -1;\n      }\n    }\n\n    if (activeIdx !== lastIdx) {\n      lastIdx = activeIdx;\n      document\n        .querySelectorAll('#dot-nav .dot')\n        .forEach((dot, i) => {\n          dot.classList.toggle(\n            'active',\n            i === activeIdx\n          );\n        });\n    }\n\n    requestAnimationFrame(tick);\n  }\n\n  requestAnimationFrame(tick);\n})();\n<\/script>\n\n\n\n<div class=\"wp-block-group container is-layout-constrained wp-block-group-is-layout-constrained\" style=\"padding-top:3rem;padding-bottom:2rem\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\" style=\"padding-top:0;padding-right:0rem;padding-bottom:0;padding-left:0rem;flex-basis:33.33%\">\n<!-- EDIT ONLY THIS SECTION -->\n\n<script>\nconst sections = [\n  {\n    id: 'lignes-directrices',\n    label: 'Lignes directrices consensuelles'\n  },\n  {\n    id: 'fmc',\n    label: 'Formation m\u00e9dicale continue'\n  },\n  {\n    id: 'gmpq',\n    label: 'Soutien au Groupe des maladies plasmocytaires du Qu\u00e9bec'\n  }\n];\n<\/script>\n\n<!-- STYLES -->\n\n<style>\n.toc-link {\n  transition: color 0.2s;\n}\n\n.toc-link:hover {\n  color: #a6192e;\n}\n<\/style>\n\n<!-- MENU -->\n\n<p style=\"\n    font-size:12px;\n    letter-spacing:0.08em;\n    text-transform:uppercase;\n    color:#888;\n    margin:0 0 1.25rem;\n    font-weight:500;\n    font-family:'Proxima Nova',sans-serif;\n  \">\n  On this page\n<\/p>\n\n<div id=\"toc-container\"><\/div>\n\n<!-- SCRIPT -->\n\n<script>\n(function () {\n\n  const container =\n    document.getElementById('toc-container');\n\n  sections.forEach((section, index) => {\n\n    const border =\n      index < sections.length - 1\n        ? 'border-bottom:1px solid #eee;'\n        : '';\n\n    container.insertAdjacentHTML(\n      'beforeend',\n      `\n      <a\n        href=\"#${section.id}\"\n        class=\"toc-link\"\n        style=\"\n          display:block;\n          padding:0.75rem 0;\n          text-decoration:none;\n          color:inherit;\n          font-size:14px;\n          font-family:'Proxima Nova',sans-serif;\n        \"\n      >\n        ${section.label}\n      <\/a>\n      `\n    );\n\n  });\n\n})();\n<\/script>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center has-custom-css is-layout-flow wp-block-column-is-layout-flow wp-custom-css-72084af9\" style=\"flex-basis:66.66%\">\n<h2 class=\"wp-block-heading\">Transfert des connaissances et impact clinique<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><glwrap>Gr\u00e2ce \u00e0 l&rsquo;initiative Aurelia, My\u00e9lome Canada veille \u00e0 ce que les avanc\u00e9es de la recherche se traduisent rapidement en am\u00e9liorations concr\u00e8tes des soins aux patients. En facilitant le transfert des connaissances de la recherche vers la pratique clinique, Aurelia r\u00e9unit chercheurs, cliniciens et personnes atteintes d&rsquo;un my\u00e9lome afin de co\u00e9laborer et d&rsquo;acc\u00e9l\u00e9rer l&rsquo;adoption de lignes directrices canadiennes consensuelles, fond\u00e9es sur des donn\u00e9es probantes, qui d\u00e9finissent les meilleures pratiques cliniques pour les Canadiens touch\u00e9s par la maladie. En cons\u00e9quence, les nouvelles d\u00e9couvertes sont partag\u00e9es plus rapidement, int\u00e9gr\u00e9es plus t\u00f4t aux soins et se traduisent par de meilleurs r\u00e9sultats pour les personnes atteintes d&rsquo;un my\u00e9lome.<\/glwrap><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\t<div data-anchor-name=\"lignes-directrices\"\n         id=\"lignes-directrices\"\n         class=\"master-anchor-block wp-elements-1\"\n    ><\/div>\n<div class=\" content-2-block wp-elements-1   block_6c5eb810a11b7a429a97d329e2d60cc3 mobile_img_first     has-image no-margin-top  \" style=\"padding-top: 2rem;padding-bottom: 2rem;background-color: var(--lb--light-grey);color: #3E3A3B;\">\n    <div class=\"container\">\n        <div class=\"grid-content-2\">\n                            <div class=\"img-wrapper \">\n                    <img loading=\"lazy\" decoding=\"async\" width=\"720\" height=\"720\" src=\"https:\/\/myeloma.ca\/wp-content\/uploads\/2023\/09\/myeloma_consensus_guideline_hero.jpg\" class=\"content-2-img\" alt=\"Vue de dessous, deux personnes noires et deux personnes blanches se tiennent les mains.\" srcset=\"https:\/\/myeloma.ca\/wp-content\/uploads\/2023\/09\/myeloma_consensus_guideline_hero.jpg 720w, https:\/\/myeloma.ca\/wp-content\/uploads\/2023\/09\/myeloma_consensus_guideline_hero-300x300.jpg 300w, https:\/\/myeloma.ca\/wp-content\/uploads\/2023\/09\/myeloma_consensus_guideline_hero-150x150.jpg 150w\" sizes=\"auto, (max-width: 720px) 100vw, 720px\" \/>                <\/div>\n                        <div class=\"content\">\n                <div>\n\t\t\t\t\t\t\t\t\t\t<h2>Lignes directrices consensuelles sur le my\u00e9lome<\/h2>\n<p>Afin de mieux harmoniser le diagnostic, les traitements et la prise en charge du my\u00e9lome partout au pays, My\u00e9lome Canada a pilot\u00e9 l\u2019\u00e9laboration des premi\u00e8res lignes directrices consensuelles canadiennes, fond\u00e9es sur des donn\u00e9es probantes, en collaboration avec des sp\u00e9cialistes de renom. \u00c9valu\u00e9es par des pairs, ces lignes directrices proposent des recommandations nationales appuy\u00e9es sur les meilleures pratiques, tout en tenant compte des r\u00e9alit\u00e9s provinciales en mati\u00e8re d\u2019acc\u00e8s et de financement. Con\u00e7ues pour \u00eatre \u00e0 la fois pratiques et pertinentes, elles offrent aux cliniciens des rep\u00e8res clairs pour le diagnostic et le traitement, contribuant ainsi \u00e0 garantir des soins plus standardis\u00e9s et de haute qualit\u00e9 aux personnes atteintes d\u2019un my\u00e9lome, peu importe o\u00f9 elles vivent au Canada.<\/p>\n<div class=\"lb-button-wrapper\"><a class=\"btn-with-icon \" target=\"_self\" href=\"https:\/\/myeloma.ca\/fr\/science-et-recherche\/lignes-directrices-du-traitement\/\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" width=\"20\" height=\"20\" viewBox=\"0 0 20 20\"> <g transform=\"translate(-406 -2843)\"> <circle cx=\"10\" cy=\"10\" r=\"10\" transform=\"translate(406 2843)\" fill=\"#1c596c\"\/> <g transform=\"translate(412.135 2845)\"> <g transform=\"translate(10.732 7.866) rotate(135)\"> <path d=\"M0,4.968V0H4.968\" transform=\"translate(3.389 2.774)\" fill=\"none\" stroke=\"#fff\" stroke-linecap=\"round\" stroke-miterlimit=\"10\" stroke-width=\"1\"\/> <\/g> <\/g> <\/g> <\/svg><span>Lignes directrices publi\u00e9es<\/span><\/a><\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n\t<div data-anchor-name=\"fmc\"\n         id=\"fmc\"\n         class=\"master-anchor-block wp-elements-2\"\n    ><\/div>\n<div class=\" content-2-block wp-elements-2   block_ecfbce874ff0491412e36a24eddfc60d      has-image no-margin-top inverted \" style=\"padding-top: 2rem;padding-bottom: 2rem;background-color: var(--lb--white);color: #3E3A3B;\">\n    <div class=\"container\">\n        <div class=\"grid-content-2\">\n                            <div class=\"img-wrapper \">\n                    <img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/myeloma.ca\/wp-content\/uploads\/2024\/04\/51071131967_f4106d393a_o-1024x683.jpg\" class=\"content-2-img\" alt=\"\" srcset=\"https:\/\/myeloma.ca\/wp-content\/uploads\/2024\/04\/51071131967_f4106d393a_o-1024x683.jpg 1024w, https:\/\/myeloma.ca\/wp-content\/uploads\/2024\/04\/51071131967_f4106d393a_o-300x200.jpg 300w, https:\/\/myeloma.ca\/wp-content\/uploads\/2024\/04\/51071131967_f4106d393a_o-768x512.jpg 768w, https:\/\/myeloma.ca\/wp-content\/uploads\/2024\/04\/51071131967_f4106d393a_o-1536x1024.jpg 1536w, https:\/\/myeloma.ca\/wp-content\/uploads\/2024\/04\/51071131967_f4106d393a_o-2048x1365.jpg 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/>                <\/div>\n                        <div class=\"content\">\n                <div>\n\t\t\t\t\t\t\t\t\t\t<h2>Formation m\u00e9dicale continue (FMC) pour les fournisseurs de soins primaires<\/h2>\n<p>My\u00e9lome Canada s&rsquo;est associ\u00e9 \u00e0 l&rsquo;Universit\u00e9 Queen&rsquo;s afin de d\u00e9velopper un programme de formation m\u00e9dicale continue (FMC), accr\u00e9dit\u00e9 et offert sur demande, destin\u00e9 aux fournisseurs de soins de sant\u00e9 primaires. Ce programme vise \u00e0 approfondir les connaissances li\u00e9es au diagnostic du my\u00e9lome, aux parcours d&rsquo;orientation vers les soins sp\u00e9cialis\u00e9s et \u00e0 la prise en charge continue de la maladie. En am\u00e9liorant la compr\u00e9hension et la coordination des soins, il favorise un acc\u00e8s plus rapide aux sp\u00e9cialistes et une prise en charge plus harmonis\u00e9e et efficace pour les patients, \u00e0 chaque \u00e9tape de leur parcours.<\/p>\n<div class=\"lb-button-wrapper\"><a class=\"btn-with-icon \" target=\"_self\" href=\"https:\/\/myeloma.ca\/fr\/professionnels-de-la-sante\/formation-medicale-continue-pour-les-fournisseurs-de-soins-primaires\/\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" width=\"20\" height=\"20\" viewBox=\"0 0 20 20\"> <g transform=\"translate(-406 -2843)\"> <circle cx=\"10\" cy=\"10\" r=\"10\" transform=\"translate(406 2843)\" fill=\"#1c596c\"\/> <g transform=\"translate(412.135 2845)\"> <g transform=\"translate(10.732 7.866) rotate(135)\"> <path d=\"M0,4.968V0H4.968\" transform=\"translate(3.389 2.774)\" fill=\"none\" stroke=\"#fff\" stroke-linecap=\"round\" stroke-miterlimit=\"10\" stroke-width=\"1\"\/> <\/g> <\/g> <\/g> <\/svg><span>En savoir plus sur notre programme FMC<\/span><\/a><\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n\t<div data-anchor-name=\"gmpq\"\n         id=\"gmpq\"\n         class=\"master-anchor-block wp-elements-3\"\n    ><\/div>\n<div class=\" content-2-block wp-elements-3   block_46519529ded4b3aaa003b9bc5dcb6186      has-image no-margin-top  \" style=\"padding-top: 2rem;padding-bottom: 2rem;background-color: var(--lb--white);color: #3E3A3B;\">\n    <div class=\"container\">\n        <div class=\"grid-content-2\">\n                            <div class=\"img-wrapper \">\n                    <img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/myeloma.ca\/wp-content\/uploads\/2026\/03\/Doctor-and-patient-1024x683.jpg\" class=\"content-2-img\" alt=\"\" srcset=\"https:\/\/myeloma.ca\/wp-content\/uploads\/2026\/03\/Doctor-and-patient-1024x683.jpg 1024w, https:\/\/myeloma.ca\/wp-content\/uploads\/2026\/03\/Doctor-and-patient-300x200.jpg 300w, https:\/\/myeloma.ca\/wp-content\/uploads\/2026\/03\/Doctor-and-patient-768x512.jpg 768w, https:\/\/myeloma.ca\/wp-content\/uploads\/2026\/03\/Doctor-and-patient-1536x1024.jpg 1536w, https:\/\/myeloma.ca\/wp-content\/uploads\/2026\/03\/Doctor-and-patient-2048x1365.jpg 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/>                <\/div>\n                        <div class=\"content\">\n                <div>\n\t\t\t\t\t\t\t\t\t\t<h2>Soutien au Groupe des maladies plasmocytaires du Qu\u00e9bec<\/h2>\n<p>Le Groupe des maladies plasmocytaires du Qu\u00e9bec (GMPQ) est un organisme qu\u00e9b\u00e9cois \u00e0 but non lucratif qui r\u00e9unit des m\u00e9decins sp\u00e9cialistes des maladies plasmocytaires. Sa mission est de promouvoir l\u2019excellence des soins li\u00e9s au traitement du my\u00e9lome multiple au Qu\u00e9bec, notamment en favorisant la diffusion des connaissances et la recherche clinique.<\/p>\n<p>My\u00e9lome Canada soutient le GMPQ depuis sa cr\u00e9ation en 2021. Dans un premier temps, l\u2019organisme a offert un appui en nature pour l\u2019\u00e9laboration des deux premi\u00e8res lignes directrices du GMPQ sur le traitement du my\u00e9lome. Depuis 2024, My\u00e9lome Canada fournit un soutien financier pour appuyer leurs activit\u00e9s \u00e9ducatives, ce qui contribue \u00e0 assurer que les personnes vivant avec le my\u00e9lome au Qu\u00e9bec b\u00e9n\u00e9ficient de soins \u00e0 jour, fond\u00e9s sur les meilleures donn\u00e9es probantes disponibles.<\/p>\n<div class=\"lb-button-wrapper\"><a class=\"btn-with-icon \" target=\"_blank\" href=\"https:\/\/gmpq.org\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" width=\"20\" height=\"20\" viewBox=\"0 0 20 20\"> <g transform=\"translate(-406 -2843)\"> <circle cx=\"10\" cy=\"10\" r=\"10\" transform=\"translate(406 2843)\" fill=\"#1c596c\"\/> <g transform=\"translate(412.135 2845)\"> <g transform=\"translate(10.732 7.866) rotate(135)\"> <path d=\"M0,4.968V0H4.968\" transform=\"translate(3.389 2.774)\" fill=\"none\" stroke=\"#fff\" stroke-linecap=\"round\" stroke-miterlimit=\"10\" stroke-width=\"1\"\/> <\/g> <\/g> <\/g> <\/svg><span>En savoir plus sur le GMPG<\/span><\/a><\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>On this page Transfert des connaissances et impact clinique<\/p>\n","protected":false},"author":10,"featured_media":0,"parent":6268,"menu_order":165,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"tags":[],"class_list":["post-33304","page","type-page","status-publish","hentry"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"On this page Transfert des connaissances et impact clinique\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/myeloma.ca\/fr\/science-et-recherche\/formation-clinique\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"fr_FR\" \/>\n\t\t<meta property=\"og:site_name\" content=\"My\u00e9lome Canada |\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Formation clinique et lignes directrices | My\u00e9lome Canada\" \/>\n\t\t<meta property=\"og:description\" content=\"On this page Transfert des connaissances et impact clinique\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/myeloma.ca\/fr\/science-et-recherche\/formation-clinique\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-03-23T19:15:44+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-07-30T21:15:21+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Formation clinique et lignes directrices | My\u00e9lome Canada\" \/>\n\t\t<meta name=\"twitter:description\" content=\"On this page Transfert des connaissances et impact clinique\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/science-et-recherche\\\/formation-clinique\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#listItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/science-et-recherche\\\/#listItem\",\"name\":\"Science et recherche\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/science-et-recherche\\\/#listItem\",\"position\":2,\"name\":\"Science et recherche\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/science-et-recherche\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/science-et-recherche\\\/formation-clinique\\\/#listItem\",\"name\":\"Formation clinique et lignes directrices\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#listItem\",\"name\":\"Accueil\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/science-et-recherche\\\/formation-clinique\\\/#listItem\",\"position\":3,\"name\":\"Formation clinique et lignes directrices\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/science-et-recherche\\\/#listItem\",\"name\":\"Science et recherche\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\",\"name\":\"Myeloma Canada\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"telephone\":\"+18887985771\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/stage.myeloma.ca\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo_en.png\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/science-et-recherche\\\/formation-clinique\\\/#organizationLogo\"},\"image\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/science-et-recherche\\\/formation-clinique\\\/#organizationLogo\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/science-et-recherche\\\/formation-clinique\\\/#webpage\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/science-et-recherche\\\/formation-clinique\\\/\",\"name\":\"Formation clinique et lignes directrices | My\\u00e9lome Canada\",\"description\":\"On this page Transfert des connaissances et impact clinique\",\"inLanguage\":\"fr-FR\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/science-et-recherche\\\/formation-clinique\\\/#breadcrumblist\"},\"datePublished\":\"2026-03-23T14:15:44-05:00\",\"dateModified\":\"2026-07-30T16:15:21-05:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"name\":\"Myeloma Canada\",\"inLanguage\":\"fr-FR\",\"publisher\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Formation clinique et lignes directrices | My\u00e9lome Canada","description":"On this page Transfert des connaissances et impact clinique","canonical_url":"https:\/\/myeloma.ca\/fr\/science-et-recherche\/formation-clinique\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/myeloma.ca\/fr\/science-et-recherche\/formation-clinique\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/#listItem","position":1,"name":"Accueil","item":"https:\/\/myeloma.ca\/fr\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/science-et-recherche\/#listItem","name":"Science et recherche"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/science-et-recherche\/#listItem","position":2,"name":"Science et recherche","item":"https:\/\/myeloma.ca\/fr\/science-et-recherche\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/science-et-recherche\/formation-clinique\/#listItem","name":"Formation clinique et lignes directrices"},"previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/#listItem","name":"Accueil"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/science-et-recherche\/formation-clinique\/#listItem","position":3,"name":"Formation clinique et lignes directrices","previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/science-et-recherche\/#listItem","name":"Science et recherche"}}]},{"@type":"Organization","@id":"https:\/\/myeloma.ca\/fr\/#organization","name":"Myeloma Canada","url":"https:\/\/myeloma.ca\/fr\/","telephone":"+18887985771","logo":{"@type":"ImageObject","url":"https:\/\/stage.myeloma.ca\/wp-content\/uploads\/2023\/02\/logo_en.png","@id":"https:\/\/myeloma.ca\/fr\/science-et-recherche\/formation-clinique\/#organizationLogo"},"image":{"@id":"https:\/\/myeloma.ca\/fr\/science-et-recherche\/formation-clinique\/#organizationLogo"}},{"@type":"WebPage","@id":"https:\/\/myeloma.ca\/fr\/science-et-recherche\/formation-clinique\/#webpage","url":"https:\/\/myeloma.ca\/fr\/science-et-recherche\/formation-clinique\/","name":"Formation clinique et lignes directrices | My\u00e9lome Canada","description":"On this page Transfert des connaissances et impact clinique","inLanguage":"fr-FR","isPartOf":{"@id":"https:\/\/myeloma.ca\/fr\/#website"},"breadcrumb":{"@id":"https:\/\/myeloma.ca\/fr\/science-et-recherche\/formation-clinique\/#breadcrumblist"},"datePublished":"2026-03-23T14:15:44-05:00","dateModified":"2026-07-30T16:15:21-05:00"},{"@type":"WebSite","@id":"https:\/\/myeloma.ca\/fr\/#website","url":"https:\/\/myeloma.ca\/fr\/","name":"Myeloma Canada","inLanguage":"fr-FR","publisher":{"@id":"https:\/\/myeloma.ca\/fr\/#organization"}}]},"og:locale":"fr_FR","og:site_name":"My\u00e9lome Canada |","og:type":"article","og:title":"Formation clinique et lignes directrices | My\u00e9lome Canada","og:description":"On this page Transfert des connaissances et impact clinique","og:url":"https:\/\/myeloma.ca\/fr\/science-et-recherche\/formation-clinique\/","article:published_time":"2026-03-23T19:15:44+00:00","article:modified_time":"2026-07-30T21:15:21+00:00","twitter:card":"summary_large_image","twitter:title":"Formation clinique et lignes directrices | My\u00e9lome Canada","twitter:description":"On this page Transfert des connaissances et impact clinique"},"aioseo_meta_data":{"post_id":"33304","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":[],"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2026-04-30 06:10:32","updated":"2026-07-30 21:58:06","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/pages\/33304","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=33304"}],"version-history":[{"count":20,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/pages\/33304\/revisions"}],"predecessor-version":[{"id":36529,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/pages\/33304\/revisions\/36529"}],"up":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/pages\/6268"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=33304"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=33304"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}